BLINCYTO Trademark

Trademark Overview

On Tuesday, January 29, 2013, a trademark application was filed for BLINCYTO with the United States Patent and Trademark Office. The USPTO has given the BLINCYTO trademark a serial number of 85835756. The federal status of this trademark filing is REGISTERED AND RENEWED as of Thursday, August 7, 2025. This trademark is owned by Amgen Inc.. The BLINCYTO trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for use in the treatment of tumorous diseases, B-cell disorders, autoimmune diseases, inflammation, infectious diseases and minimal residual disease
blincyto

General Information

Serial Number85835756
Word MarkBLINCYTO
Filing DateTuesday, January 29, 2013
Status800 - REGISTERED AND RENEWED
Status DateThursday, August 7, 2025
Registration Number4712947
Registration DateTuesday, March 31, 2015
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, November 12, 2013

Trademark Statements

Goods and ServicesPharmaceutical preparations for use in the treatment of tumorous diseases, B-cell disorders, autoimmune diseases, inflammation, infectious diseases and minimal residual disease

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, February 5, 2013
Primary Code005
First Use Anywhere DateWednesday, December 17, 2014
First Use In Commerce DateWednesday, December 17, 2014

Trademark Owner History

Party NameAmgen Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressThousand Oaks, CA 91320-1799
Party NameAmgen Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressThousand Oaks, CA 913201799
Party NameAmgen Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressThousand Oaks, CA 913201799

Trademark Events

Event DateEvent Description
Friday, February 1, 2013NEW APPLICATION ENTERED
Tuesday, February 5, 2013NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, May 8, 2013ASSIGNED TO EXAMINER
Monday, September 16, 2013TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, September 27, 2013APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, May 14, 2013PRIORITY ACTION WRITTEN
Tuesday, May 14, 2013PRIORITY ACTION E-MAILED
Tuesday, May 14, 2013NOTIFICATION OF PRIORITY ACTION E-MAILED
Monday, September 16, 2013CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, September 16, 2013TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, October 10, 2013LAW OFFICE PUBLICATION REVIEW COMPLETED
Tuesday, November 12, 2013OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, January 7, 2014NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Friday, May 23, 2014SOU TEAS EXTENSION RECEIVED
Friday, May 23, 2014SOU EXTENSION 1 FILED
Friday, May 23, 2014SOU EXTENSION 1 GRANTED
Tuesday, May 27, 2014NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, December 18, 2014TEAS STATEMENT OF USE RECEIVED
Thursday, October 10, 2013ASSIGNED TO LIE
Wednesday, October 23, 2013NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, November 12, 2013PUBLISHED FOR OPPOSITION
Thursday, January 29, 2015CASE ASSIGNED TO INTENT TO USE PARALEGAL
Thursday, February 26, 2015ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Tuesday, March 31, 2015REGISTERED-PRINCIPAL REGISTER
Thursday, August 2, 2018TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, March 7, 2019TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Sunday, December 28, 2014USE AMENDMENT FILED
Saturday, January 31, 2015STATEMENT OF USE PROCESSING COMPLETE
Friday, February 27, 2015NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Thursday, August 2, 2018ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, June 3, 2021REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Friday, April 29, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, March 7, 2019ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, March 31, 2020COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Tuesday, February 2, 2021TEAS SECTION 8 & 15 RECEIVED
Thursday, June 3, 2021CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Thursday, June 3, 2021NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
Friday, April 29, 2022TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Friday, April 29, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, April 29, 2022APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Friday, April 29, 2022TEAS CHANGE OF OWNER ADDRESS RECEIVED
Friday, April 29, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, February 25, 2025TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Sunday, March 31, 2024COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
Tuesday, February 25, 2025APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Tuesday, February 25, 2025ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, February 25, 2025TEAS CHANGE OF OWNER ADDRESS RECEIVED
Tuesday, February 25, 2025TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, August 7, 2025CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Thursday, August 7, 2025REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
Thursday, August 7, 2025NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
Thursday, August 7, 2025REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
Friday, March 21, 2025TEAS SECTION 8 & 9 RECEIVED

Related Keywords

blincyto diseases infectious inflammation minimal disease residual autoimmune disorders preparations treatment